David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.45% |
| 2 | Consumer Discretionary | 10.49% |
| 3 | Communication Services | 9.04% |
| 4 | Healthcare | 8.89% |
| 5 | Financials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Donaldson
DCI
$10.8B
| $11.9M | 0.01% |
204,323
-2,048
| -1% | -$122K |
|
|
EXPR
1152
DELISTED
Express, Inc.
EXPR
| $11.8M | 0.01% |
147,378
+145,407
| +7,377% | +$9.12M |
|
1153
Realty Income
O
$59.5B
| $11.8M | 0.01% |
192,017
-309,804
| -62% | -$18.4M |
|
1154
SEI Investments
SEIC
$13.3B
| $11.8M | 0.01% |
193,441
+31,855
| +20% | +$1.87M |
|
1155
Lattice Semiconductor
LSCC
$16.5B
| $11.8M | 0.01% |
261,746
+126,692
| +94% | +$5.62M |
|
1156
Denali Therapeutics
DNLI
$3.98B
| $11.8M | 0.01% |
206,162
+126,802
| +160% | +$8.49M |
|
1157
Gildan
GIL
$10.1B
| $11.7M | 0.01% |
381,280
-144,920
| -28% | -$4.13M |
|
|
FTCH
1158
CALL
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $11.7M | 0.01% |
220,000
-62,700
| -22% | -$3.84M |
|
1159
Arcosa
ACA
$7.13B
| $11.7M | 0.01% |
179,082
-61,358
| -26% | -$3.77M |
|
|
CCXI
1160
DELISTED
ChemoCentryx, Inc.
CCXI
| $11.6M | 0.01% |
227,273
-469,821
| -67% | -$28.3M |
|
1161
BP
BP
$110B
| $11.6M | 0.01% |
478,197
+103,471
| +28% | +$2.49M |
|
1162
Ashland
ASH
$3.38B
| $11.6M | 0.01% |
130,993
-75,525
| -37% | -$6.51M |
|
1163
Cars.com
CARS
$661M
| $11.6M | 0.01% |
896,574
-377,117
| -30% | -$4.94M |
|
1164
CALL
Lowe's Companies
LOW
$120B
| $11.6M | 0.01% |
60,800
+5,400
| +10% | +$927K |
|
1165
MacroGenics
MGNX
$266M
| $11.5M | 0.01% |
362,417
-204,987
| -36% | -$4.98M |
|
|
PRPB
1166
DELISTED
CC Neuberger Principal Holdings II Class A Ordinary Shares
PRPB
| $11.4M | 0.01% |
1,160,528
+310,528
| +37% | +$3.25M |
|
|
EQC
1167
DELISTED
Equity Commonwealth
EQC
| $11.4M | 0.01% |
411,048
-287,152
| -41% | -$8.11M |
|
1168
PUT
Credit Acceptance
CACC
$6.27B
| $11.4M | 0.01% |
31,700
+1,700
| +6% | +$616K |
|
1169
LiveRamp
RAMP
$2.29B
| $11.4M | 0.01% |
219,757
+188,272
| +598% | +$12.8M |
|
1170
Broadridge
BR
$21.1B
| $11.4M | 0.01% |
74,294
+55,984
| +306% | +$8.27M |
|
1171
AMC Global Media
AMCX
$530M
| $11.4M | 0.01% |
+213,639
| New | +$11.7M |
|
1172
CALL
Zebra Technologies
ZBRA
$17.1B
| $11.4M | 0.01% |
23,400
+9,700
| +71% | +$4.33M |
|
|
ARCH
1173
DELISTED
Arch Resources, Inc.
ARCH
| $11.4M | 0.01% |
272,853
+128,289
| +89% | +$6.18M |
|
1174
Vanda Pharmaceuticals
VNDA
$329M
| $11.3M | 0.01% |
754,429
+341,970
| +83% | +$5.54M |
|
1175
CALL
Appian
APPN
$2.84B
| $11.3M | 0.01% |
85,200
+50,000
| +142% | +$8.85M |
|
Similar funds
David Shaw's Q1 2021 Portfolio in Review
As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
David Shaw withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, David Shaw opened a new position in Baidu worth $627M.
- David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
- David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- David Shaw opened 825 new positions and closed 730 in Q1 2021.
- David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.